-40%
BLOOMBERG LAW PATENTS AND THE FEDERAL CIRCUIT 2016
$ 23.76
- Description
- Size Guide
Description
This landmark reference deals with both the high-profile cases and the “uncelebrated decisions” that tend to slip under the radar and fits them into an analytical framework that reveals their true significance.Patents and the Federal Circuit
addresses ever-changing issues and developments in substantive patent law, infringement litigation, and procedure. The authors distill the opinions issued by the primary source of governing law on patents, providing convenient, one-source access to controlling case law.
The
Fourteenth Edition
includes a new appendix with guidance on the time to decision for the Federal Circuit’s patent decisions, including statistics on the time from argument to issuance of a precedential decision by judge.
Discussion of new Supreme Court and key Federal Circuit decisions include:
Supreme Court decisions through June 2019, including
Helsinn Healthcare SA v. Teva Pharmaceuticals USA Inc
., 139 S. Ct. 628 (2019), and
Return Mail, Inc. v. U.S. Postal Serv.
, 139 S. Ct. 1853, 1867 (2019).
Decisions concerning the Federal Circuit’s evolving precedent on patent eligibility under 35 U.S.C. 101, including,
inter alia
,
Roche Molecular Sys., Inc. v. Cepheid
, 905 F.3d 1363, 1372 (Fed. Cir. 2018);
SAP Am., Inc. v. InvestPic, LLC
, 898 F.3d 1161, 1162 (Fed. Cir. 2018);
Voter Verified, Inc. v. Election Sys. & Software, LLC
, 887 F.3d 1376 (Fed. Cir. 2018);
Aatrix Software, Inc. v. Green Shades Software, Inc
., 882 F.3d 1121, 1125 (Fed. Cir. 2018);
Berkheimer v. HP, Inc
., 881 F.3d 1360 (Fed. Cir. 2018);
Praxair Distrib. v. Mallinckrodt Hosp. Prods. IP
, 890 F.3d 1024, 1032 (Fed. Cir. 2018);
In re Marco Guldenaar Holding B.V.
, 911 F.3d 1157 (Fed. Cir. 2018);
In re Nordt Dev. Co., LLC
, 881 F.3d 1371, 1374-75 (Fed. Cir. 2018); and
Vanda Pharms. Inc. v. West-Ward Pharms. Int’l Ltd
., 887 F.3d 1117, 1121 (Fed. Cir. 2018).
Revisions to address U.S. Patent Trial and Appeal Board procedure for post-grant proceedings under the America Invents Act in light of the rapidly-evolving law in this area